FDA

Week in Review

Week in Review

Confirmation hearing for OIRA nominee, Supreme Court takings decision, CFPB offers exemptions, and more…

FTC Report Shows Increase in Pay-for-Delay Drug Settlements

FTC Report Shows Increase in Pay-for-Delay Drug Settlements

Agency report indicates that potentially anti-competitive drug settlements are on the rise.

Institutionalizing Regulatory Lookback

Institutionalizing Regulatory Lookback

Obama’s next OIRA Administrator should act to embed retrospective evaluation into the regulatory process.

Agencies Act to Address Risks from Sun Exposure

Agencies Act to Address Risks from Sun Exposure

U.S. government takes measures to protect public from excessive sun exposure.

Policy Entrepreneurs: The Power of Audacity

Policy Entrepreneurs: The Power of Audacity

What can the efforts of a single former OIRA official teach about making broad institutional changes?

Week in Review

Week in Review

Obama signs executive order to share government information, Republicans block EPA nominee, and more.

New York City Unleashes a Flood of Open Data

New York City Unleashes a Flood of Open Data

Law promises to promote transparency and encourage technological innovation.

Week in Review

Week in Review

Supreme Court will not hear tobacco labeling case, Administration releases new drug policy, and more.

Week in Review

Week in Review

FTC cracks down on cell phone cramming, gun control bill hits wall in Senate, and more.

Protecting Children from Bioterrorism and Biomedical Research

Protecting Children from Bioterrorism and Biomedical Research

Bioethics Commission weighs in on ethical ways to test anthrax vaccines on children.

Week in Review

Week in Review

FHFA proposes alternative to Fannie and Freddie, TSA to allow pocket knives onto planes, and more.

FDA Convenes Public Meeting on Proposed Food Safety Rules

FDA Convenes Public Meeting on Proposed Food Safety Rules

Industry lobbyists and safety advocates testify to the benefits and burdens of two major proposed rules.